ArticleAnnals of translational medicine2020

Ligustilide alleviates podocyte injury via suppressing the SIRT1/NF-κB signaling pathways in rats with diabetic nephropathy.

Feng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.